THE NEW ROLE OF PHARMACOTHERAPY FOR WEIGHT REDUCTION IN OBESITY
2002; Wiley; Volume: 56; Issue: 9 Linguagem: Inglês
10.1111/j.1742-1241.2002.tb11352.x
ISSN1742-1241
Autores Tópico(s)Pharmacology and Obesity Treatment
ResumoSUMMARY Obesity is associated with an increased risk for a wide variety of chronic health conditions. Despite this fact, less than half of obese patients are advised by healthcare professionals to lose weight. Creating a viable plan for losing weight and maintaining weight loss is difficult. Lifestyle change is always the cornerstone of treatment, but two new therapeutic agents approved for long‐term use, sibutramine and orlistat, can help maximise success. Increased weight loss can lead to reductions in the risk of obesity‐related co‐morbidities. Sibutramine and orlistat offer new weight reduction opportunities for obese patients.
Referência(s)